- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03320577
Pranayama Breathing and Uncontrolled Hypertension
Take a Deep Breath: Randomized Controlled Trial of the Effects of Breathing Exercises on Blood Pressure
Study Overview
Status
Conditions
Detailed Description
Untreated or uncontrolled hypertension is a leading cause of heart disease, stroke, and kidney failure. Hypertension, is a modifiable risk factor that may be successfully treated using one or a combination of treatment options, including medication, diet, exercise, tobacco cessation, or complementary and alternative medicine such as breathing exercises. A well-established cascade of adverse health outcomes are associated with hypertension as well as increased mortality rates. For patient-centered care, providing patients with additional strategies for their health care also has the potential to empower the patient, augment patient-physician team approach to the patient's health care, and support the standards of care for treating hypertension. As explained by McCaffrey et al from their focus group work with patients, "Participants do not want prescription medications except as a last resort and feel that conventional medicine overemphasizes prescription medicines. This may be because of a combination of factors including distrust in conventional medicine, fear of side effects from medicines, and an underlying belief that the body can heal itself given the right nutrition, rest, and time"
Using a randomized controlled trial study design with a 1-month and 3-month follow-up, the investigators hypothesize that practicing breathing at least 5 times per week will show a mean reduction in systolic (SBP) and diastolic (DBP) blood pressures in uncontrolled hypertensive patients compared to control patients. Participants will be randomized into one of three arms of the study. For the intervention arm, participants will be either assigned to a weekly class for the pranayama breathing instruction and practice or given a DVD that contains instructions on the breathing exercises and the 15-minute practice session.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Missouri
-
Columbia, Missouri, United States, 65212
- University of Missouri-Columbia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria
- English-speaking adults
- less than 60 years of age with BP measurements of ≥140/ ≥90 mm Hg
- 60 years of age or older with BP measurements of ≥150/ ≥90 mm Hg
- diagnosed with diabetes with BP measurements of ≥140/ ≥90 mm Hg
- Patients with BP measurements of <180/ <110 mm Hg without hypertensive urgency symptoms
Exclusion Criteria:
comorbidities of COPD, renal disease or chronic alcoholism
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Class instruction of breathing exercises
Class participation/instruction weekly for 6 weeks and requested to practice Pranayama breathing exercises of 15 minute duration for an additional 4x during the week; completed log that indicated time/date/duration of practice; weekly blood pressure measurements and turn in logs; week 10 and week 18 blood pressure measurements also obtained.
Survey instruments completed at baseline, week 6, 10, 18.
|
Pranayama Breathing exercises practiced at least 5 times a week and log practice times
|
|
Active Comparator: DVD instruction of breathing exercises
Received DVD with instructions and 15 minute Pranayama breathing exercises of 15 minute duration.
Participants requested to practice breathing exercises 5x during the week for 6 week intervention; completed log that indicated time/date/duration of practice; weekly blood pressure measurements and turn in logs; week 10 and week 18 blood pressure measurements also obtained.
Survey instruments completed at baseline, week 6, 10, 18.
|
Pranayama Breathing exercises practiced at least 5 times a week and log practice times
|
|
Placebo Comparator: Control
Completed log that indicated time of eating dinner; weekly blood pressure measurements for the 6 week intervention; control participants also turned in dinner time logs; week 10 and week 18 blood pressure measurements also obtained.
Survey instruments completed at baseline, week 6, 10, 18.
|
Log dinner times
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduced blood pressure from breathing exercises
Time Frame: Baseline to week 10
|
5 mmHg point reduction in blood pressure (dichotomous variable) associated with breathing exercises
|
Baseline to week 10
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Beta blocker medication affect on blood pressure reduction
Time Frame: Baseline to week 6
|
Differences on blood pressure (mean mmHg) reduction stratified by use of beta blockers (dichotomous)
|
Baseline to week 6
|
|
Perceived political stress level of participant affect on blood pressure reduction
Time Frame: Baseline to week 10
|
Differences on blood pressure (mean mmHg / dichotomous 5 mmHg reduction) reduction stratified by participants reported stress using one question about stress related to the 2016 elelction rated on a 5-point Likert scale from high stress (extremely-somewhat) to low stress (slightly-not at all); range 5-1;
|
Baseline to week 10
|
|
Self Efficacy response to breathing exercises
Time Frame: Baseline to week 18
|
General self efficacy scale ( point change; range: 10-40) increase in response to breathing exercises
|
Baseline to week 18
|
|
Depressive severity response to breathing exercises
Time Frame: Baseline to week 18
|
% participants who had PHQ-9 Patient Health Questionnaire which screens for depression (score <5 or >9; range 0-27) in response to breathing exercises
|
Baseline to week 18
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jane A McElroy, PhD, University of Missouri-Columbia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2005875
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Uncontrolled Hypertension
-
Qilu Pharmaceutical Co., Ltd.Not yet recruitingUncontrolled Hypertension
-
Colleen J KleinEnrolling by invitationUncontrolled HypertensionUnited States
-
Qilu Pharmaceutical Co., Ltd.Not yet recruitingUncontrolled HypertensionChina
-
Heart Center Leipzig - University HospitalActive, not recruitingArterial Hypertension | Uncontrolled HypertensionGermany
-
AstraZenecaCompleted
-
Shanghai Golden Leaf MedTec Co. LtdEuropean Cardiovascular Research CenterWithdrawnUncontrolled HypertensionSwitzerland
-
CVRx, Inc.Suspended
-
Verve Medical, IncClinical Accelerator (CRO); Israeli-Georgian Medical Research Clinic Helsicore and other collaboratorsActive, not recruitingHypertension | Uncontrolled HypertensionGeorgia
-
Abbott Medical DevicesCompletedUncontrolled HypertensionSpain, Belgium, Estonia, Italy, Portugal, United Kingdom
-
Medtronic VascularCompletedUncontrolled HypertensionUnited States
Clinical Trials on Class instruction of breathing exercises
-
Massachusetts General HospitalCompletedParkinson Disease | Movement Disorders | Neuro-Degenerative DiseaseUnited States
-
Federal University of PelotasNot yet recruitingDepressive Symptoms | Anxiety Symptoms
-
Derya AzimCompletedStroke | Physiotherapy and RehabilitationTurkey
-
Uppsala UniversityThe Swedish Research Council; Örebro County CouncilCompleted
-
Riphah International UniversityCompleted
-
Cairo UniversityCompleted
-
Rawan Mohammed Khairy Mostafa ElsawyCairo UniversityRecruitingChild, Only | Pulmonary Function | Functional Capacity | Thalassemia Major | Incentive SpirometerEgypt
-
Atlas UniversityCompleted
-
Riphah International UniversityCompletedPost Covid-19 PatientsPakistan
-
Federal University of BahiaCompletedParkinson Disease | DysphagiaBrazil